INNOVEX INTERNATIONAL INC (INVX) Fundamental Analysis & Valuation

NYSE:INVX • US4576511079

Current stock price

24.79 USD
+0.39 (+1.6%)
At close:
24.71 USD
-0.08 (-0.32%)
Pre-Market:

This INVX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. INVX Profitability Analysis

1.1 Basic Checks

  • INVX had positive earnings in the past year.
  • INVX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: INVX reported negative net income in multiple years.
  • Of the past 5 years INVX 4 years had a positive operating cash flow.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • INVX has a better Return On Assets (6.57%) than 83.33% of its industry peers.
  • The Return On Equity of INVX (7.88%) is better than 73.33% of its industry peers.
  • INVX's Return On Invested Capital of 8.28% is fine compared to the rest of the industry. INVX outperforms 71.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for INVX is significantly below the industry average of 13.38%.
  • The 3 year average ROIC (5.11%) for INVX is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROIC 8.28%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of INVX (8.51%) is better than 75.00% of its industry peers.
  • Looking at the Operating Margin, with a value of 11.63%, INVX is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
  • INVX has a Gross Margin of 31.00%. This is in the better half of the industry: INVX outperforms 70.00% of its industry peers.
  • INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.63%
PM (TTM) 8.51%
GM 31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. INVX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INVX is destroying value.
  • INVX has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for INVX has been increased compared to 5 years ago.
  • INVX has a better debt/assets ratio than last year.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • An Altman-Z score of 6.81 indicates that INVX is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.81, INVX belongs to the top of the industry, outperforming 98.33% of the companies in the same industry.
  • INVX has a debt to FCF ratio of 0.16. This is a very positive value and a sign of high solvency as it would only need 0.16 years to pay back of all of its debts.
  • INVX's Debt to FCF ratio of 0.16 is amongst the best of the industry. INVX outperforms 95.00% of its industry peers.
  • INVX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • INVX has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. INVX outperforms 88.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Altman-Z 6.81
ROIC/WACC0.93
WACC8.86%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 4.91 indicates that INVX has no problem at all paying its short term obligations.
  • INVX has a better Current ratio (4.91) than 95.00% of its industry peers.
  • INVX has a Quick Ratio of 3.24. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.24, INVX belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.91
Quick Ratio 3.24
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. INVX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 382.35% over the past year.
  • The Earnings Per Share has been growing by 74.11% on average over the past years. This is a very strong growth
  • Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 26.86%.
  • The Revenue has been growing by 21.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)382.35%
EPS 3YN/A
EPS 5Y74.11%
EPS Q2Q%2.86%
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%

3.2 Future

  • INVX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.83% yearly.
  • The Revenue is expected to grow by 4.22% on average over the next years.
EPS Next Y57.04%
EPS Next 2Y37.29%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year3.85%
Revenue Next 2Y4.57%
Revenue Next 3Y4.22%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

7

4. INVX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.82, INVX can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, INVX is valued a bit cheaper than 66.67% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. INVX is around the same levels.
  • INVX is valuated correctly with a Price/Forward Earnings ratio of 16.44.
  • INVX's Price/Forward Earnings ratio is rather cheap when compared to the industry. INVX is cheaper than 83.33% of the companies in the same industry.
  • INVX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.51.
Industry RankSector Rank
PE 25.82
Fwd PE 16.44
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVX indicates a somewhat cheap valuation: INVX is cheaper than 61.67% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11
EV/EBITDA 8.8
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of INVX may justify a higher PE ratio.
  • INVX's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)0.35
EPS Next 2Y37.29%
EPS Next 3Y26.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVX Dividend Analysis

5.1 Amount

  • No dividends for INVX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVX Fundamentals: All Metrics, Ratios and Statistics

INNOVEX INTERNATIONAL INC

NYSE:INVX (3/26/2026, 8:04:00 PM)

Premarket: 24.71 -0.08 (-0.32%)

24.79

+0.39 (+1.6%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-23
Earnings (Next)N/A
Inst Owners47.97%
Inst Owner Change3.68%
Ins Owners1.52%
Ins Owner Change0.58%
Market Cap1.71B
Revenue(TTM)978.25M
Net Income(TTM)83.30M
Analysts80
Price Target25.5 (2.86%)
Short Float %N/A
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.3%
Min EPS beat(2)-62.53%
Max EPS beat(2)7.93%
EPS beat(4)1
Avg EPS beat(4)-25.34%
Min EPS beat(4)-62.53%
Max EPS beat(4)7.93%
EPS beat(8)2
Avg EPS beat(8)-131.99%
EPS beat(12)2
Avg EPS beat(12)-130.16%
EPS beat(16)4
Avg EPS beat(16)-71.22%
Revenue beat(2)2
Avg Revenue beat(2)16.02%
Min Revenue beat(2)8.43%
Max Revenue beat(2)23.61%
Revenue beat(4)3
Avg Revenue beat(4)8.69%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)23.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.29%
EPS NQ rev (1m)-23.9%
EPS NQ rev (3m)-23.9%
EPS NY rev (1m)-7.57%
EPS NY rev (3m)-7.57%
Revenue NQ rev (1m)2.22%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.49%
Valuation
Industry RankSector Rank
PE 25.82
Fwd PE 16.44
P/S 1.75
P/FCF 11
P/OCF 8.98
P/B 1.62
P/tB 2.04
EV/EBITDA 8.8
EPS(TTM)0.96
EY3.87%
EPS(NY)1.51
Fwd EY6.08%
FCF(TTM)2.25
FCFY9.09%
OCF(TTM)2.76
OCFY11.14%
SpS14.15
BVpS15.3
TBVpS12.17
PEG (NY)0.45
PEG (5Y)0.35
Graham Number18.18
Profitability
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROCE 10.15%
ROIC 8.28%
ROICexc 10.12%
ROICexgc 13.23%
OM 11.63%
PM (TTM) 8.51%
GM 31%
FCFM 15.92%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)5.92%
ROICexc(5y)N/A
ROICexgc(3y)7.49%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Debt/EBITDA 0.11
Cap/Depr 57.84%
Cap/Sales 3.59%
Interest Coverage 111.19
Cash Conversion 109.41%
Profit Quality 187.02%
Current Ratio 4.91
Quick Ratio 3.24
Altman-Z 6.81
F-Score7
WACC8.86%
ROIC/WACC0.93
Cap/Depr(3y)69.66%
Cap/Depr(5y)61.2%
Cap/Sales(3y)4.45%
Cap/Sales(5y)4.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)382.35%
EPS 3YN/A
EPS 5Y74.11%
EPS Q2Q%2.86%
EPS Next Y57.04%
EPS Next 2Y37.29%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%
Revenue Next Year3.85%
Revenue Next 2Y4.57%
Revenue Next 3Y4.22%
Revenue Next 5YN/A
EBIT growth 1Y26.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.05%
EBIT Next 3Y28.79%
EBIT Next 5YN/A
FCF growth 1Y95.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.32%
OCF growth 3YN/A
OCF growth 5YN/A

INNOVEX INTERNATIONAL INC / INVX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 7 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Undervalued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 9 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.